Livionex Pharma

Executive Summary

Livionex Pharma is a US-based biotechnology company specializing in advanced oral care through its proprietary drug delivery platform. Founded in 2010 and headquartered in Los Gatos, California, the company markets LIVFRESH gel toothpaste and mouthwash, which are clinically proven to remove plaque and improve gum health significantly better than leading brands. The key differentiator is its patented ingredient, Activated Edathamil, which disrupts plaque at a molecular level. Livionex targets the large and growing oral care market, positioning itself as a science-based alternative to conventional products. As a private company with no disclosed funding rounds or valuation, Livionex appears to be in an early commercial stage, relying on direct-to-consumer and potentially retail distribution. The company's success hinges on consumer adoption and competitive positioning against established players like Colgate and Procter & Gamble. While the clinical data supports superior efficacy, widespread market penetration remains a challenge.

Upcoming Catalysts (preview)

• Q3 2026Retail distribution expansion (e.g., Walmart, CVS)40% success
• Q4 2026Publication of new clinical study or FDA clearance for additional indication30% success
• H2 2026Partnership or licensing deal with larger oral care or pharmaceutical company25% success